Stay updated on RC48-ADC in Low HER2 Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    First Hospital of China Medical University was added as a study site and First Affiliated Hospital of China Medical University was removed. The document revision was updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-19T13:58:21.000Z thumbnail image
  2. Check
    15 days ago
    No Change Detected
  3. Check
    22 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T20:22:00.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a minor software update with no visible changes to study content.
    Difference
    0.0%
    Check dated 2026-03-07T05:56:53.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2. The study details page content remains unchanged.
    Difference
    0.0%
    Check dated 2026-02-13T13:37:33.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Version bump from v3.4.0 to v3.4.1. No visible changes to the study details page.
    Difference
    0.0%
    Check dated 2026-02-06T09:14:21.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4. No substantive study information appears to be modified.
    Difference
    0.0%
    Check dated 2026-01-15T05:00:54.000Z thumbnail image

Stay in the know with updates to RC48-ADC in Low HER2 Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page.